Small Pharma Reports Fiscal Third Quarter 2023 Highlights
Positive top-line results from Phase IIa trial of SPL026 in Major Depressive Disorder New SPL026 trials underway and screening commenced in the first...
Source: globenewswire.com
Page 6 - Eric Ribner News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eric Ribner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eric Ribner Today - Breaking & Trending Today
Small Pharma To Support University College London Research Project on Neuroplasticity
LONDON, Dec. 14, 2022 -- Small Pharma Inc. , a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that it will provide its... | December 15, 2022
Source: marketscreener.com
Eyenovia to Present at Upcoming BTIG Ophthalmology Day
23.11.2022 - NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) - Eyenovia, Inc. (Nasdaq: EYEN), a pre-commercial ophthalmic technology company developing the Optejet delivery system for use both in combination with its own drug-device therapeutic programs for ...
Source: wallstreet-online.de
Second United States Patent Granted for Small Pharma's
Brings total to twelve granted patents across the Company’s full portfolio LONDON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT)...
Source: globenewswire.com
Small Pharma Reports Fiscal Second Quarter 2023 Highlights
Last patient dosed in Phase IIa trial for lead product candidate, SPL026 with supportive therapy for the treatment of Major Depressive Disorder Completion...
Source: globenewswire.com